Kidney Research UK has responded to the National Institute for Health and Care Excellence (NICE) draft guidance on therapeutics for patients with COVID-19.
It follows the regulatory body’s decision to significantly reduce the number of treatments available. The charity moved to highlight the evidence that failed to consider the impact on high-risk patients and also strongly supported the case for fast-tracking of potential COVID-19 treatments…
